No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes

No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes

Bibliographic Details
Main Authors:	Czeizel Andrew, Dudás István, Gidai János, Horváth-Puhó Erzsébet
Format:	Article
Language:	English
Published:	De Gruyter 2008-03-01
Series:	Open Medicine
Subjects:	human chorionic gonadotropin pregnancy threatened abortion preterm birth low birthweight newborns
Online Access:	https://doi.org/10.2478/s11536-007-0056-9

Similar Items

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
by: Regina Lee, et al.
Published: (2015-04-01)

Effect of exogenous human chorionic gonadotropin on ovulation in mice
by: S. Ya. Amstislavsky, et al.
Published: (2020-01-01)

Differential diagnosis of elevated human chorionic gonadotropin in women
by: Anthony Williams
Published: (2023-03-01)

THE ROLE OF HUMAN CHORIONIC GONADOTROPIN IN THE TREATMENT OF RETRACTILE TESTIS
by: Sadik Hasan Kaddim
Published: (2016-12-01)

Unusual false-negative serum human chorionic gonadotropin detected by qualitative immunoassay: a case report of two Iraqi women
by: Falah H.O Al-Khikani, et al.
Published: (2020-01-01)

Unnecessary test ordering in clinical trials: human chorionic gonadotropin as an example
by: Alegre Estibaliz, et al.
Published: (2020-01-01)

Fetal gender, serum human chorionic gonadotropin, and testosterone in women with preeclampsia
by: Zakia M. Ibrahim, et al.
Published: (2020-07-01)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
by: Vinayak Madhusoodanan, et al.
Published: (2019-11-01)

EFFECTS OF PROGESTERONE IN THREATENED ABORTION
by: N Sakhavar,, et al.
Published: (2008-10-01)

Advanced esophageal carcinoma expressing Human Chorionic Gonadotropin (HCG-b)
by: Kutty Geeta, et al.
Published: (2013-01-01)

Persistently elevated β-human chorionic gonadotropin level after vacuum-assisted uterine aspiration: a case report
by: Annika Sinha, et al.
Published: (2022-07-01)

Comparison of Human Chorionic Gonadotropin Test and Amnisure Test for Diagnosis of Premature Rapture of Membrane
by: Esmat Barooti, et al.
Published: (2019-01-01)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
by: Wilhelmina Bagchus, et al.
Published: (2018-01-01)

Success rate of undescended testicle treatment with human chorionic gonadotropin
by: Ležakov Ognjen, et al.
Published: (2019-01-01)

Should human chorionic gonadotropine treatment increase thyroid volume?
by: Ayten Oguz, et al.
Published: (2015-08-01)

Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy
by: Allison A. Gockley, et al.
Published: (2021-08-01)

Use of Human Chorionic Gonadotropin and Vaginal Progesterone Suppositories For Luteal Phase Support in Gonadotropin-Induced Cycles: A Comparative Study
by: Emel Ebru Özçimen, et al.
Published: (2006-04-01)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
by: Alpana De, et al.
Published: (2018-12-01)

Evaluation of Endometrial Angiogenesis in Mice Uterus Before Implantation in Natural Cycles Followed by Use of Human Menopausal Gonadotropin - Human Chorionic Gonadotropin Drugs and Epigallocatechin Gallate
by: Bahman Rashidi, et al.
Published: (2017-01-01)

Testicular Torsion: Preliminary Results of In Vitro Cell Stimulation Using Chorionic Gonadotropin
by: Andrea Errico, et al.
Published: (2022-01-01)

Impact of intrauterine administration of human chorionic gonadotropin before intrauterine insemination in infertile women: A randomized controlled trial
by: Leena Wadhwa, et al.
Published: (2021-01-01)

Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy
by: Arash Derakhshan, et al.
Published: (2023-08-01)

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy
by: Chiara Dallagiovanna, et al.
Published: (2022-01-01)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
by: ShuQin Liu, et al.
Published: (2017-12-01)

Human chorionic gonadotropin (hCG)-induced ovulation occurs later but with equal occurrence in lactating dairy cows: comparing hCG and gonadotropin-releasing hormone protocols
by: Tsung-Ching LIU, et al.
Published: (2019-10-01)

Salivary human chorionic gonadotropin as a novel biomarker for early detection of pregnancy: A pilot study
by: Madhura Mahajan, et al.
Published: (2019-01-01)

Immunoassay for Human Chorionic Gonadotropin Based on Glassy Carbon Electrode Modified with an Epitaxial Nanocomposite
by: Akram Valipour, et al.
Published: (2017-06-01)

Acquired uterine vascular abnormalities associated with persistent human chorionic gonadotropin: Experience at a Korean teaching hospital
by: Da Hye Ju, et al.
Published: (2015-12-01)

Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2020-01-01)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
by: Yeon Hee Hong, et al.
Published: (2022-01-01)

Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology
by: Deepika Pratap, et al.
Published: (2014-01-01)

Expression of beta-human chorionic gonadotropin as a prognostic factor in colorectal carcinoma
by: Hameed Naeem Mosa, et al.
Published: (2019-01-01)

Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
by: Koji Yoshimura, et al.

Endocrine dysfunction in Taiwanese children with human chorionic gonadotropin-secreting germ cell tumors
by: Chien-Ming Lin, et al.
Published: (2014-02-01)

PREDICTING THE EFFECTIVENESS OF HUMAN CHORIONIC GONADOTROPIN IN THE TREATMENT OF INFERTILITY AND HYPOGONADISM IN MEN
by: D. G. Pochernikov, et al.
Published: (2018-05-01)

Effect of intramuscular injection of human chorionic gonadotropin on endometrium preparation in frozen-thawed embryo transfer cycle: A randomized clinical trial
by: Firoozeh Akbari Asbagh, et al.
Published: (2023-03-01)

Clinical outcomes of assisted reproductive technology treatment by using a self‐injection of recombinant human chorionic gonadotropin as the final maturation trigger
by: Koji Nakagawa, et al.
Published: (2018-04-01)

Effects of human chorionic gonadotropin intrauterine injection on oocyte retrieval day on assisted reproductive techniques outcomes: An RCT
by: Robabe Hosseinisadat, et al.
Published: (2021-09-01)

To compare the effect of GnRH agonist versus human chorionic gonadotropin (HCG) trigger on clinical pregnancy rate in intrauterine insemination cycle
by: Rashmi Sharma, et al.
Published: (2021-01-01)

Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin
by: Hirokazu Usui, et al.
Published: (2023-11-01)